Effectiveness of Vedolizumab in Patients With Inflammatory Bowel Disease and Concomitant Primary Sclerosing Cholangitis

被引：0
|
作者：
Santiago, Priscila [1 ]
Robateau, Anthony [1 ]
Lopdrup, Rachel G. [2 ]
Neto, Manuel B. Braga [1 ]
Raffals, Laura [1 ]
Eaton, John [1 ]
Ramos, Guilherme [1 ]
Loftus, Edward V. [3 ]
机构：
[1] Mayo Clin Rochester, Rochester, MN USA
[2] Aurora Hlth Care, Milwaukee, WI USA
[3] Mayo Clin Rochester, Coll Med & Sci, Rochester, MN USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S955
引用
收藏
页码：S688 / S689
页数：2
相关论文
共 50 条
  • [31] Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review
    Da Cunha, Teresa
    Vaziri, Haleh
    Wu, George Y.
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (03) : 531 - 542
  • [32] Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID
    Caron, B.
    Peyrin-Biroulet, L.
    Nachury, M.
    Bouhnik, Y.
    Seksik, P.
    Bouguen, G.
    Caillo, L.
    Laharie, D.
    Carbonnel, F.
    Altwegg, R.
    Reenaers, C.
    Serrero, M.
    Boureille, A.
    Nancey, S.
    Filippi, J.
    Abitbol, V.
    Savoye, G.
    Vuitton, L.
    Viennot, S.
    Fumery, M.
    Reymond, M.
    Bronowicki, J. P.
    Reimund, J. -M.
    Amiot, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S278 - S278
  • [33] EFFECT OF VEDOLIZUMAB, INFLIXIMAB, AND ADALIMUMAB ON BILIARY INFLAMMATION IN INDIVIDUALS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE
    Tse, Chung Sang
    Raffals, Laura H.
    Loftus, Edward V.
    Gossard, Andrea
    Lightner, Amy L.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S302 - S303
  • [34] EFFICACY OF VEDOLIZUMAB IN REDUCING BILIARY INFLAMMATION IN PRIMARY SCLEROSING CHOLANGITIS (PSC) IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
    Tse, Chung Sang
    Loftus, Edward V.
    Raffals, Laura H.
    Gossard, Andrea
    Lightner, Amy L.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S402 - S403
  • [35] Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease
    Tse, C. S.
    Loftus, E. V., Jr.
    Raffals, L. E.
    Gossard, A. A.
    Lightner, A. L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (02) : 190 - 195
  • [36] Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease
    O'Toole, Aoibhlinn
    Alakkari, Alaa
    Keegan, Denise
    Doherty, Glen
    Mulcahy, Hugh
    O'Donoghue, Diarmuid
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (04) : 439 - 441
  • [37] Screening primary sclerosing cholangitis (PSC) in patients with inflammatory bowel disease (IBD)
    Farkkila, M
    Karvonen, AL
    Pikkarainen, P
    Nurmi, H
    Nuutinen, H
    Karkkainen, P
    Mattila, J
    Taavitsainen, M
    Miettinen, A
    [J]. GUT, 1997, 41 : A178 - A178
  • [38] Inflammatory bowel disease in patients undergoing liver transplantation for primary sclerosing cholangitis
    Mathy, C
    Terrault, N
    Mahadevan, U
    Bostrom, A
    Terdiman, J
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A219 - A219
  • [39] Inflammatory Bowel Disease Is Associated With Poor Outcomes of Patients With Primary Sclerosing Cholangitis
    Ngu, Jing Hieng
    Gearry, Richard Blair
    Wright, Andrew Jeffrey
    Stedman, Catherine Ann Malcolm
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (12) : 1092 - 1097
  • [40] Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis
    Imam, M. H.
    Thackeray, E. W.
    Lindor, K. D.
    [J]. COLORECTAL DISEASE, 2013, 15 (02) : 198 - 203
12345